Invention Grant
- Patent Title: Triazole compounds that modulate HSP90 activity
-
Application No.: US13857665Application Date: 2013-04-05
-
Publication No.: US08835464B2Publication Date: 2014-09-16
- Inventor: Lijun Sun , Weiwen Ying , Junghyun Chae , Teresa Kowalczyk-Prezewloka , Shijie Zhang , Dinesh U. Chimmanamada , Kevin Paul Foley , Zhenjian Du , Hao Li , David James , Howard P. Ng , Zachary Demko , Dan Zhou , Shuzhen Qin
- Applicant: Synta Pharmaceuticals Corp.
- Applicant Address: US MA Lexington
- Assignee: Synta Pharmaceuticals Corp.
- Current Assignee: Synta Pharmaceuticals Corp.
- Current Assignee Address: US MA Lexington
- Agency: McCarter & English, LLP
- Agent Steven G. Davis
- Main IPC: A61K31/4439
- IPC: A61K31/4439 ; C07D401/04 ; C07D401/14
Abstract:
The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for preventing or treating hyperproliferative disorders, such as cancer, in a subject in need thereof comprising administering to the subject a substituted triazole compound of the invention, or a composition comprising such a compound.
Public/Granted literature
- US20130296378A1 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY Public/Granted day:2013-11-07
Information query
IPC分类:
